The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology

Journal of Nuclear Medicine

Volumn 53, Issue 8, 2012, Pages 1175-1184

  Kurdziel, Karen A ^a   Shih, Joanna H ^a   Apolo, Andrea B ^a   Lindenberg, Liza ^a   Mena, Esther ^a   McKinney, Yolanda Y ^a   Adler, Stephen S ^a   Turkbey, Baris ^a   Dahut, William ^a   Gulley, James L ^a   Madan, Ravi A ^a   Landgren, Ola ^a   Choyke, Peter L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Bone scanning; Multiple myeloma; Oncology; PET CT; Prostate cancer

Indexed keywords

SODIUM FLUORIDE F 18; DIAGNOSTIC AGENT; FLUORIDE SODIUM; FLUORINE;

ACCURACY; ADULT; AGED; ARTICLE; AUTOMATION; BLADDER; BONE MARROW; CANCER PATIENT; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DOSIMETRY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; IMAGE RECONSTRUCTION; KINETICS; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; ONCOLOGY; OSTEOBLAST; PRECANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RADIATION EXPOSURE; RECOMMENDED DRUG DOSE; REPRODUCIBILITY; THREE DIMENSIONAL IMAGING; WHOLE BODY CT; WHOLE BODY PET; CLINICAL TRIAL; INSTRUMENTATION; METABOLISM; METHODOLOGY; NEOPLASM; POSITRON EMISSION TOMOGRAPHY; RADIOMETRY; SCINTISCANNING; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; FLUORINE RADIOISOTOPES; HUMANS; KINETICS; MALE; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOMETRY; SODIUM FLUORIDE;

EID: 84864755813     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.100883     Document Type: Article

References (22)

1. Blau M, Ganatra R, Bender MA. 18 F-fluoride for bone imaging. Semin Nucl Med. 1972;2:31-37.
2. French RJ, McCready VR. The use of 18-F for bone scanning. Br J Radiol. 1967;40:655-661.
3. Surti S, Kuhn A, Werner ME, Perkins AE, Kolthammer J, Karp JS. Performance of Philips Gemini TF PET/CT scanner with special consideration for its time-of-flight imaging capabilities. J Nucl Med. 2007;48:471-480. (Pubitemid 47604933)
4. Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023-1027. (Pubitemid 43733519)
5. International Commission on Radiological Protection (ICRP). Human alimentary tract model for radiological protection. ICRP publication 100. A report of The International Commission on Radiological Protection. Ann ICRP. 2006;36:25-327, iii.
6. Searle S. Variance Components. New York, NY: Wiley Press; 1992.
7. Levy P. The design and analysis of clinical experiments. Br J Math Stat Psychol. 1987;40:98-99.
8. Fleiss J. The design and analysis of clinical experiments. New York, NY: John Wiley & Sons; 1986.
9. Blau M, Nagler W, Bender M. Fluorine-18: a new isotope for bone scanning. J Nucl Med. 1962;3:332-334.
10. Langsteger W, Heinisch M, Fogelman I. The role of fluorodeoxyglucose, F-18-dihydroxyphenylalanine, F-18-choline, and F-18-fluoride in bone imaging with emphasis on prostate and breast. Semin Nucl Med. 2006;36: 73-92. (Pubitemid 41782168)
11. Arslandemir C, Schirrmeister H, Dziuk K, et al. Comparison of planar bone scanning with SPECT and F-18-fluoride-PET in staging lung cancer patients [abstract]. J Nucl Med. 2001;42:305P.
12. Schirrmeister H, Guhlmann A, Kotzerke J, et al. Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol. 1999;17:2381-2389. (Pubitemid 29368236)
13. Hetzel M, Arslandemir C, Konig HH, et al. F-18NaFPET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management. J Bone Miner Res. 2003;18:2206-2214. (Pubitemid 37463314)
14. Schirrmeister H, Glatting G, Hetzel J, et al. Prospective evaluation of the clinical value of planar bone scans, SPECT, and F-18-labeled NaFPET in newly diagnosed lung cancer. J Nucl Med. 2001;42:1800-1804. (Pubitemid 34016348)
15. Hoh CK, Hawkins RA, Dahlbom M, et al. Whole-body skeletal imaging with [F-18] fluoride-ion and PET. J Comput Assist Tomogr. 1993;17:34-41. (Pubitemid 23029796)
16. 18F-fluoride PET/CT. J Nucl Med. 2006;47: 287-297.
17. Positron Emission Tomography CMS. (PET) (NaF-18) to identify bone metastasis of cancer. MLN Matters. Available at: https://www.cms.gov/ MLNMattersArticles/downloads/MM6861.pdf. Accessed June 8, 2012.
18. Cancer tracer synthesis resources. National Cancer Institute Web site. Available at: http://imaging.cancer.gov/programsandresources/cancer-tracer- synthesis-resources. Accessed June 8, 2012.
19. 18Ffluoride PET/CT bone scans 1.0. J Nucl Med. 2010;51:1813-1820.
20. 18F-fluoride: applying new technology to an old tracer. J Nucl Med. 2008; 49:68-78.
21. International Commission on Radiological Protection (ICRP). Radiation dose to patients from radiopharmaceuticals. A report of a Task Group of Committee 2 of the International Commission on Radiological Protection. Ann ICRP. 1987;18:1-377.
22. Blake GM, Park-Holohan SJ, Cook GJR, Fogelman I. Quantitative studies of bone with the use of F-18-fluoride and Tc-99m-methylene diphosphonate. Semin Nucl Med. 2001;31:28-49. (Pubitemid 32060651)